NK3-specific natural killer cells are selectively inhibited by Bw4- positive HLA alleles with isoleucine 80 by unknown
NK3-specific Natural Killer Cells Are 
Selectively Inhibited by Bw4-positive HLA Alleles 
with Isoleucine 80 
By Marina  Cella,*  Anna Longo,*  Giovan  Battista  Ferrara,* 
Jack  L.  Strominger,~  and Marco  Colonna*$ 
From the  *Istituto Nazionale per la Ricerca sul Cancrg  16132 Genova, Italy; the *Department 
of Biochemistry and Molecular Biology, Harvard University, Cambridgg  Massachusetts 02138; 
and the SBasel Institute for Immunology,  Basel CH-4005, Switzerland 
Summary 
Natural kiUer (NK) cell dones have been previously described which are inhibited by HLA-C 
aUdes with Asn77-LysS0 (NKl-specific cdls) or by HLA-C alldes with Ser77-Asn80  (NK2- 
specific ceils). In the present work, the generation of NK cells with HLA-B-rdated spedficities 
was attempted by stimulation of a Bw4 homozygous responder by a Bw6 homozygous donor. 
Two NK clones were found, which were inhibited by HLA-Bw4 (but not by HLA-Bw6) allotypes 
and by some HLA-A allotypes that share the Bw4 public epitope. Inhibition of NK cell-mediated 
lysis strongly correlated with the presence of an Ile residue at position 80 of the protective allele. 
These NK cdl dones define a new specificity termed NK3. 
N 
'K cells display cytolytic activity against tumor and vitally 
infected cells that is not restricted by the MHC (1, 2). 
However, target susceptibility of NK cell-mediated lysis is 
influenced by the expression ofMHC dass I proteins on target 
cells (3). NK-resistant cells become susceptible to NK cyto- 
toxicity as a result of deletion of class I genes by mutagen- 
esis; transfection of class I genes into these mutated cell lines 
restores  the original resistance to lysis (4). This protective 
effect of class I antigens on NK cell-mediated lysis is influenced 
by their polymorphism. While HLA-A2 does not protect 
from NK lysis in one system, a single amino acid change at 
position 74  confers  a  protective effect  on  HLA-A2  (5). 
Moreover,  five different subsets of NK cells with apparent 
allospedficities have been defined based on differential  pat- 
terns of lysis on PHA-activated T  cell blasts  (6).  For two 
of these subsets a dimorphism of HLA-C at positions 77-80 
has been shown to control susceptibility/resistance of targets 
to lysis (7-10). 
Recently, a variable degree of protection from lysis by NK 
cell clones has been described for several HLA-A and -B al- 
Ides, although the polymorphic amino acid residues respon- 
sible for these differences have not been identified (11). In 
the present work, the role of residues 77-83 of HLA-B was 
investigated with respect to target susceptibility/resistance  to 
lysis by NK cells. These positions are characterized by a dimor- 
phism as found in HLA-C,  which is associated with the 
Bw4/Bw6 epitopes identified by human aUoantisera (12-15). 
Bw4 and Bw6 are supertypic (public) specificities that are 
shared by several HLA-B and a few HLA-A and -C alldes 
(rather than characterizing individual alleles) and are the earliest 
HLA public specificities described. No comparable HLA al- 
loantisera that recognize the HLA-C dimorphism have been 
identified. A number of NK clones were derived from a Bw4- 
positive donor and tested for their cytotoxicity on HLA trans- 
fectants  of MHC class I-defident cell lines and on PHA- 
activated T  cell blasts.  Cytotoxicity patterns of two clones 
revealed an inhibitory role of the Bw4 epitope on NK lysis 
that particularly correlated with the presence of an Ile res- 
idue at position 80. These dones define a new HLA-B-related 
NK specificity, termed NK3. 
Materials and Methods 
NK Celt Clones.  CD3-, CD4-, CD8-  NK cells were pre- 
pared from an HLA-typed bloo.d donor (HLA-A2, A3, B5, B58, 
Bw4, CwT, DRS, DRS, DR52, DQ7) as previously  described  (9). 
They were cloned by limiting dilution at a concentration of one 
to five  ceUs/well  in 96-well  U-bottom  phtes in the presence  of PHA 
(0.1% vol/vol; Difco  Laboratories, Detroit, MI), riD2 (1,000 U/ml, 
Hoffman-La Roche,  Nutley, NJ), 10%  leukocyte-conditioned 
medium (LCM)  1 (16) and feeder calls. These consisted of 104 ir- 
radiated (5,000 rad) calls/well of the B-lymphoblastoid cell line 
(B-LCL) RPMI 8866, which promotes NK cell proliferation (17), 
and 3  x  104 irradiated (3,000 tad) PBMC/weU from an HLA- 
typed donor (HLA-A2, A26, B35, B61, Bw6, Cw2, Cw4, DR4, 
DR5). After 10 d, proliferating  cultures were transferred to 96-well 
1 Abbreviations used in this paper: B-LCL, B-lymphobhstoid cell line; LCM, 
leukocyte-conditioned medium. 
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NK cell clones were restimulated with feeder cells every 3-4 wk. 
1 wk after the hst stimulation, the clones were screened in func- 
tional assays. Cytofluommetric analysis  and cytotmdc assays  were 
as previously described (9). The target  cell panel included the 
prcmrythroblastic  cell line K562, HLA class I-deficient B-LCLs  C1R 
and 721.221 (4, 18), HLA-B transfectants of CIR (4, 11) (gener- 
ously provided by Dr. Lewis L. Lanier, DNAX Research Institute 
of Molecular and Cellular Biology, Palo Alto, CA), HLA-C trans- 
fectants of 721.221 (10, 19, 20), and PHA-activated T cell blasts 
from HLA-typed  random  donors. These  were  prepared  by culturing 
PBMC in the presence of PHA (0.1% vol/vol) and recombinant 
Ib2 (100 U/ml) for 4 d. HLA class I typing was performed using 
a standard microlympbocytotoxicity assay. 
PCR-Oligonudeotide Typing.  A 188-bp fragment of the second 
exon of HLA-B was selectively  amplified  from genomic DNAs by 
the PCR. The primers used for amplification  were GGACG(A/G)- 
CAC(G/C)C(A/T)GTTCGTGA (5', nucleotides  83-102 and CGG- 
CCTCGCTC'IGGTTGTAG  (3; nucleotides 251-270) (21). De- 
generate positions are shown in parenthesis. PCR was performed 
for 33 cycles, each of 30.s steps at 96  ~ 55  ~ and 72~  Amplified 
fragments were denatured in 0.4 M NaOH/25 mM ~  and 
applied to a nylon membrane (Zeta-probe; Bio Red Laboratories, 
Cambridge, MA) with a dot blot apparatus (Bio Dot; Bio Bad 
Laboratories). Membranes were hybridized with sq~-hbeled oligo- 
nudeotides  specific for  Ile 80  (CCTGCGGATCGCGCTCCG- 
CTAC, nudeotides 230-251), Thr 80 (CCTC~GGACCCTGCT- 
CCGCTAC, nucleotides 230-251 of HLA-B27, -B37, -B47 and 
AACUIGCGCACCGCGCTCC, nucleotides  228-246 of HLA-B13 
and -B44), and Ash80 (CCTGCGGAACCTGCGCGGC, nucleo- 
tides 230-248) (21). Hybridization was carried out as described  (7). 
Samples that were negative for lie 80 in HLA-B were subsequently 
typed for the presence of Ile 80 in HLA-A. A 81-bp fragment of 
the second exon of HLA-A was amplified from genomic DNAs 
by PCIL using the 5' primer CA(C/G)GGAA(T/A)(A/G)TGA- 
AGCK2CCA(G/C)T (nucleotides 190-210), which selectively  am- 
plified HLA-A. The 3' primer was as above. 
Stasrical Methods.  The correhtion  between resistance to lysis 
by NK3-specific  cells and the presence of a Bw4-positive HLA-B 
or -A allele or the presence of Ile 80 on the target cell was tested 
for its significance  by the Wilcoxon Rank Sum test (22). The as- 
sociation between Ile, Thr, Asn at position 80 and resistance, in- 
termediate lysis and susceptibility to lysis, respectively,  was tested 
by the Kruskal-WaUis test (22). 
Results 
NK Cell Clones That Are Inhibited by HLA-B Alleles of the 
Bw4 Grou/2  Alloreacfive NK cells can be generated by stim- 
ulation across an HLA-C dimorphism involving residues 77 
and 80, i.e., by stimulating Asn77-LysS0 homozygous NK 
cells with Ser77-AsnS0 homozygous cells (NKl-specific cells) 
and vice versa (NK2-specific cells) (9). HLA-B is character- 
ized by a similar polymorphism at residues  77-83  that en- 
codes the Bw4/Bw6 epitopes recognized by human alloan- 
tisera and monodonal antibodies. However, this polymorphism 
is more complex at the DNA and protein sequence level than 
that found in HLA-C. For example,  Ih, Thr, and Ash are 
all found at position 80, and at least five different Bw4 se- 
quences  occur in this region (15). 
Nevertheless,  an attempt to establish alloreactive NK ceils 
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Figure 1.  Sensitivity  of  36 NK 
cell clones  to inhibition  by HLA-B 
alleles transfected  into C1R cells. 
The cytotaxic  activity  of  NK cell 
clones against the  B lympho- 
blastoid cell line CIR and the 
HLA-B  transfectants  of  C1R was 
determined by a 4-h slCr release 
assay. Effector/target ratio was 
10:1. $olidsquares  indicate  a strong 
inhibition  of NK lysis  of C1R by 
a transfected  HLA-B allde (the 
lysis of the transfectant  was 50% 
or less than the lysis of C1R); 
shaded squares indicate  weak  inhi- 
bition (lysis  between 50-80% of 
CIR lysis); open squares  represent 
no inhibition (lysis  <80%). 
by stimulation across the Bw4/Bw6 epitopes was made, as 
had been done for HLA-C.  CD3-, CD4-,  CDS- lympho- 
cytes were purified from a HLA-Bw4 homozygous donor 
(HLA-B5, B58) and cloned by limiting dilution in the pres- 
ence of a feeder  cell mixture, which included  irradiated  PBMC 
1236  NK3-specific  Natural Killer Cells Figure 2.  Segregation  of the 
NIO  specificity in  the  MHC 
recombinant  family  P. Cytotoxic 
activity  of  C4.253 and D6.251 cell 
dones  against  PHA bhsts derived 
from family  members  was deter- 
mined  by a 4-h slCr release  assay. 
Effeetor/target ratio was  10:1. 
Both clones gave identical pat- 
terns. Squares, males; circles, fe- 
males; solid symbols, individuals 
susceptible to lysis; open  symbols, 
individuals  resistant  to lysis.  Small 
letters indicate  HLA haplotypes. 
These  were  determined  by micro- 
lymphocytotoxicity  assay  and are 
shown below. 
from a Bw6 homozygous donor (HLA-B35,  B61)  and the 
lymphoblastoid cell line RPM18866, which selectively stimu- 
lates NK cell proliferation (17). 36 CD3-CD56 +  cell clones 
were obtained and screened for their cytotoxicity in a 4  h 
SlCr-release  assay against a target panel including the NK- 
sensitive K562  cell line,  the class I-deficient mutant C1R 
(which expresses the residual HLA-Cw4 gene) and 4 HLA-B 
transfectants of C1R (HLA-B*5801, -B'2705, -B'3701, and 
-B'0702). All the NK clones lysed K562 and C1R cells (data 
not shown).  Transfection of HLA-B*5801  (Bw4) strongly 
inhibited C1R lysis by 17 clones and weakly inhibited C1R 
lysis by 10 additional dones (Fig.  1). Among these 27 clones, 
only 4 were strongly inhibited by HLA-B*2705  (Bw4),  4 
by -B'3701  (Bw4), and 1 by HLA-B*0702 (Bw6). The cy- 
totoxicity of the nine remaining clones was not significantly 
influenced by any of the transfected HLA-B alleles (Fig.  1). 
Thus, the tested NK cell clones showed a strong sensitivity 
to inhibition by HLA-B*5801,  low sensitivity to HLA-B*2705 
and HLA-B*3701,  and almost no sensitivity to HLA-B*0702. 
These results are in agreement with the previously observed 
strong inhibitory role of HLA-B*5801, whereas a strong in- 
hibitory role of HLA-B*3701 was not observed in this study 
(11). The high frequency of clones inhibited by HLA-B*5801 
as compared to HLA-B*2705 or HLA-B*3701, all of which 
are Bw4 positive, may be related to differences in the precise 
sequences at residues 77-83  in these different alleles  (15). 
A  New Specificity (NK3) Is Defined by Cytotoxicity  of NK 
Cell Clones on PHA Blasts  Which Is Recessively Inherited and 
Controlled by HLA-R  AU the NK cell clones derived from 
the Bw4-positive donor were subsequently analyzed for their 
cytotoxicity against a target panel of PHA-activated T  cell 
blasts  obtained from members of HLA-typed families.  Of 
the 36 ceU clones tested, all of which were cytolytic on C1R 
cells, only 2 clones, C4.253 and D6.251, were cytotoxic against 
these PHA blasts.  In family P, targets from both parents (Pl 
and P2) were resistant to lysis by both of these clones, whereas 
targets from the children included both susceptible (P4 and 
PS) and resistant individuals (P3 and P6), indicating that sus- 
ceptibility to NK cell-mediated lysis is recessive, whereas re- 
sistance to lysis is dominant, as shown for all NK allospe- 
cificities previously examined (6) (Fig. 2). In addition, recessive 
susceptibility and dominant resistance were associated with 
1237  Celia et al. Table  1.  The Specificity of the NK Cell Clone D6.251 Does Not Correlate with the HLA-C Dimorphism 
That Defines NK1 and NK2 Specificities 
HLA-A  HLA-B  Bw*  HLA-C  HLA-C 77-80  Percent lysis 
BL  2,  30  35,  50  6  3,  -  $77-N80  54 
AG  2,  2  15,  18  6  3,  7  $77-N80  34 
ME  1,  2  8,  62  6  3,  7  $77-N80  29 
SG  2,  28  44,  61  4,  6  3,  7  $77-N80  0 
MM  24,  -  7,  62  4,  6  3,  7  $77-N80  3 
BP  25,  25  51,  51  4  1,  1  $77-N80  0 
PE  2,  26  35,  61  6  2,  4  N77-K80  46 
VL  2,  30  13,  41  4,  6  4,  6  N77-K80  23 
RG  2,  23  44,  18  4,  6  4,  5  N77-K80  0 
AE  2,  33  44,  17  4  3,  4  S/N77-N/K80  0 
AF  2,  33  5,  58  4  1,  6  S/N77-N/K80  0 
FL  1, 3  8,  35  6  4,  7  S/N77-N/K80  24 
C1R  -  -  -  4  N77-K80  43 
C1R tr  -  "5801  4  4  N77-K80  4 
CIR tr  -  *2705  4  4  N77-K80  20 
CIR tr  -  "3701  4  4  N77-K80  25 
CIlL tr  -  *0702  6  4  N77-K80  35 
721.221  .....  63 
721.221  tr  -  -  -  "0101  $77-N80  52 
721.221  tr  -  -  -  "0501  N77-K80  61 
721.221  tr  -  -  -  "0601  N77-K80  61 
Cytotoxicity of the D6.251 cell clone was determined by a 4-h SlCr-release assay. The target panel included PHA blasts from 12 random donors, 
C1R, HLA-B transfectants (tr) of C1R,  721.221, and HLA-C transfectants (tr) of 721.221. Effector to target ratio was 3:1. Typing of Ser (S), 
Ash (N), and Lys (K) at positions 77 and 80 was described (7). A similar cytotoxicity pattern was observed with clone C4.253. 
* See note to Table 2. 
specific MHC  haplotypes  (a/c and b/d,  respectively), sug- 
gesting that the locus controlling susceptibility/resistance to 
lysis maps within  the MHC.  This study did not allow us 
to position the locus controlling susceptibility/resistance to 
lysis with respect to the recombination breakpoint between 
HLA-A and -C of haplotype c/d identified in individual P6 
by HLA typing, because the paternal haplotype b is respon- 
sible for the resistance of this individual,  independently of 
the maternal haplotype c/d. 
Cytotoxicity patterns  of the D6.251  and C4.253  dones 
were also tested on PHA blasts  from HLA-typed random 
donors.  These patterns did not correspond to those previ- 
ously characterized for NKl-specific cells (only HLA-C Ser77- 
ASh80 homozygous cells lysed) or for NK2-specific cells (only 
HLA-C Asn77-LysS0 homozygous cells lysed) (Table 1) (7, 
9). Therefore, the C4.253 and D6.251 clones define a new 
specificity that is termed here as NK3.  The role of HLA-B 
and HLA-C in this specificity was directly investigated by 
testing the cytotoxicity of NK3-specific cell clones against 
C1R (which expresses only one class I MHC protein, HLA- 
Cw4), HLA-B transfectants of CIR, the class I-negative cell 
line 721.221, and the HLA-Cw*0101 (NK1 target), -Cw*0501, 
and -Cw*0601 (NK2 targets) transfectants of 721.221 (Table 
1).  Lysis by both clones were strongly inhibited by B'5801 
and partially by B'2705  and by B'3701,  whereas cytolytic 
activity was only slightly affected by B*0702.  In addition, 
there was no inhibition by HLA-C molecules as 721.221 and 
the HLA-C transfectants of 721.221 were lysed to the same 
extent. These results suggest that the NK3 specificity on PHA 
blasts  is controlled by HLA-B but  not by HLA-C. 
Susceptibility~Resistance ofT Cell Blasts to Cytotoxicity by NK- 
3-specific NK Cell Clones Correlates with the Polymorphisms at 
Residue 80 of  HLA-A and-18,  Cytotoxicity of NK cell clones 
C4.253 and D6.251 was tested against PHA-activated T  cell 
blasts  obtained from a  large panel  of HLA-typed random 
donors to identify the epitope controlling the NK3 specifidty 
(Table 2).  A  good lysis (>40%)  was  observed in  10 Bw6 
homozygous targets (PHA blasts 1 to 10); none of the Bw6 
1238  NK3-specific  Natural Killer Cells Table  2.  Inhibition of Cytolytic Activity of the NK3-specific Cell Clone C4.253 by PHA Blasts Carrying the Bw4 Motif 
Residue 80 
PHA blasts  HLA-A  HLA-B  Bw*  HLA-C  HLA-B  HLA-A  Percent lysis 
1.  GE  1,  3  8,  41  6  7,  -  NN  -  54 
2.  FG  11,  30  8,  55  6  3,  7  NN  -  52 
3.  AA  2,  31  35,  50  6  2,  6  NN  -  59 
4.  BR  2,  33  55,  65  6  3,  -  NN  -  63 
5.  AG  2,  2  15,  18  6  3,  7  NN  -  43 
6.  BL  2,  30  35,  50  6  3,  -  NN  -  60 
7.  ME  1,  2  8,  62  6  3,  7  NN  -  58 
8.  FL  1,  3  8,  35  6  4,  7  NN  -  49 
9.  CT  2,  3  35,  61  6  2,  4  NN  -  51 
10.  RGE  2,  3  35,  -  6  6,  4  NN  -  54 
11.  SA  1,  30  13,  37  4  6,  -  TT  -  28 
12.  RO  2,  28  18,  47  4,  6  6,  7  TN  -  22 
13.  OG  2,  28  44,  62  4,  6  3,  7  TN  -  25 
14.  DG  2,  2  18,  27  4,  6  1,  7  TN  -  29 
15.  VC  3,  30  13,  62  4,  6  3,  6  TN  -  23 
16.  FM  1,  29  27,  45  4,  6  2,  6  TN  -  17 
17.  AE  2,  33  44,  17  4  3,  4  IT  -  1 
18.  SP  2,  11  51,  57  4  1,  6  II  -  0 
19.  DE  2,  32  5,  18  4,  6  ND  IN  I  1 
20.  BS  25,  31  51,  51  4  1,  -  II  I  0 
21.  RM  2,  24  55,  49  4,  6  3,  7  IN  I  3 
22.  BG  2,  24  5,  40  4,  6  2,  5  IN  I  0 
23.  CA  2,  24  35,  27  4,  6  1,  -  TN  I  13 
24.  MM  24,  -  7,  62  4,  6  3,  7  NN  I  0 
25.  RGI  24,  -  35,  62  4,  6  3,  4  NN  I  8 
26.  GA  25,  32  35,  61  4,  6  2,  4  NN  I  1 
27.  GG  3,  24  35,  -  4,  6  4,  -  NN  I  8 
28.  NM  29,  32  44,  35  4,  6  4,  -  TN  I  0 
29.  RG  2,  23  44,  18  4,  6  4,  5  TN  I  0 
30.  PR  28,  26  12,  27  4  2,  7  TT  -  9 
31.  DGA  29, 31  35,  44  4,  6  4,  -  TN  -  2 
32.  BG  2,  29  44,  50  4,  6  6,  -  TN  -  4 
33.  RU  28,  29  47,  44  4  6,  -  TT  -  1 
34. LL  11,  29  35,  44  4,  6  4,  5  TN  -  1 
Cytotoxic activity of the C4.253 cell clone against PHA blasts derived from 34 random donors was determined by a 4-h SlCr-release assay. Effee- 
tor/target ratio was 10:1. A similar cytotoxicity pattern was observed with clone D6.251. HLA class I typing was performed by standard microlym- 
phocytotoxicity assay. (-)  The sample was either  homozygous or carried a blank allele. Ih (/), Thr (7"), and Asn (N) at position 80 in HLA-B 
or Ile (/) 80 at HLA-A were determined by oligotyping (see Materials and Methods).  The difference in level of lysis between Bw6 homozygous 
cells (PHA blasts 1 to 10) and Bw4 homozygous or heterozygous  ceils (PHA bhsts 11-34) was highly significant (p <0.0001 by the Wilcoxon Rank 
Sum test); similarly, the difference between 1 80 positive (PHA blasts 17 to 29) and 1 80 negative (PHA blasts 1-16 and 30-34) was highly significant 
(p <0.0001).  Comparison of level of lysis in three groups, 1 80 positive (PHA blasts 17-29), T 80 positive (PHA blasts 11-16 and 30-34), and NS0 
homozygous (PHA blasts  1-10), revealed a p value <0.0005 by the Kruskal-WaUis test. 
* The Bw4 motifs present at residues 77-83 were: NLILIALR in A9 (23, 24), B5 (51, 52), B17 (57, 58), B49; SLRIALR. in A25, A32; NLRTALR 
in B13, B12 (44); and DLRTLLR in B27 (B'2705 subtype), B37, B47. Other B27 subtypes can present NLILIALR, NLRTALR, and a fifth motif 
SLRTLLR. An additional Bw4 motif NLRTAAR may be found in a variant of HLA-B44  (B'4401) (23,  24). The Bw6 motif was SLP,  NLRG 
in B7, B8, B18, B41, B12 (45), B50, B55, B40 (60, 61), B15 (62), B65. HLA-A and -B alleles shown in parentheses represent a "split" serological 
specificity; for instance,  B12 has been split into B44 (Bw4) and B45 (Bw6). 
1239  Calla et al. erozygous or Thr 80 homozygous. All observed correlations 
were highly significant  statistically  (Table 2,  see legend). 
Figure 3.  Oligotyping of HLA-B and HLA-A polymorphism at posi- 
tion 80. Representative samples are shown. 
homozygous targets was resistant. A low degree of lysis (PHA 
blasts  11 to 16) or no lysis at all (PHA blasts  17 to 34) was 
observed in 24 targets; these carried a Bw4 sequence motif 
either on a HLA-B allde or on a HLA-A allele or on both 
(Table 2). Amino acid sequence comparison of alleles confer- 
ring high resistance revealed that 13/18 ceils (PHA-blasts 17 
to 29) shared Ile at position 80. The five remaining ceils that 
were highly resistant did not express HLA-A or HLA-B al- 
1des with Ile 80 (PHA blasts 30 to 34), but all typed serolog- 
ically as HLA-B44 positive. The HLA-B44 specificity is het- 
erogeneous at residues  80-83,  and some subtypes present a 
unique sequence (TAAR; Table 2) (23, 24). Most alleles of 
the Bw4 group with Thr at position 80 (including HLA- 
BD, -B27, -B37, -B47) gave an intermediate degree of lysis 
(PHA blasts  11 to 16). This correlation between suscepti- 
bility/resistance to lysis by NK3-specific  ceil clones and the 
amino acid residues at position 80 was confn'med  by genomic 
DNA typing with sequence-specific oligonudeotides (Fig. 
3). Samples resistant to NK lysis were heterozygous or homo- 
zygous for Ile 80 (or carried HLA-B44). All highly suscep- 
tible samples were homozygous for Asn 80, while samples 
with intermediate degree of lysis were Thr 80/Asn 80 her- 
Discussion 
An inhibitory role of the Bw4 motif on NK cell-medi- 
ated lysis was initially suggested by the observation that 17 
out of the 36 NK cell clones obtained from a Bw4 homozy- 
gous individual in the presence of Bw6 homozygous feeder 
ceUs were selectively inhibited by the Bw4-positive allele 
B'5801. More conclusive evidence was provided by detailed 
analysis of two of these NK clones,  which define the new 
specificity NK3. Analysis of the cytotoxicity of these NK3- 
specific  ceils against class  I ~ts  and PHA blasts demon- 
strated that HLA-B and a few HLA-A alleles with the Bw4 
motif at positions 77-83 conferred a dominant protection to 
NK3-spedfic lysis. However,  the inhibitory role of these 
HLA-A alldes requires confirmation by transfection. Heter- 
ogeneity  in the Bw4 group of alleles was also observed, which 
correlated with the amino acid residue at position 80. Ile 80 
was associated with NK inhibition, Thr 80 with an inter- 
mediate degree of lysis, and Asn 80 with complete suscepti- 
bility to lysis. This observation is consistent with the previ- 
ously observed inhibitory role of positions 77-80 of HLA-C, 
may focus attention on residue 80 and indicates that this (these) 
residue(s) in the c~1 domain of HLA-A, -B, and -C may have 
in a predominant role in protecting target cells from NK lysis. 
Residue 80 of the HLA heavy chain is located on the or1 
hdixjust beyond the COOH end of the peptide binding cleft 
and is pointing upward, accessible to recognition (25). 
Out of 17 clones which lysed CIK but not C1K/HLA- 
B'5801 transfectant, only two gave positive results in cyto- 
toxicity on the PHA blasts.  This observation may exphin 
the discrepancy between previous work identifying MHC- 
spedfic NK ceils (6) and a more recent study describing the 
lack of specific MHC recognition patterns in 120 NK doues 
tested against HLA transfectants (11). NK cells with defined 
MHC recognition pattern can be found, although these are 
present in a very low percentage of the total NK population 
(5%  in the present  study) and can only be identified by 
analyzing NK cytotoxicity on PHA blasts.  In some cases, 
the percentage of these cells in the NK population may be 
increased by allogeneic stimulation, as previously shown for 
NK1- and NK2-specific calls, although it is not known why 
proliferation occurred in this situation (9). There are several 
possible explanations for the different sensitivity of NK calls 
to inhibition by HLA alleles transfccted in B cell lines or ex- 
pressed on PHA blasts.  First, HLA molecules may display 
a different expression level or conformation on the two cell 
types.  Second, molecules other  than  MHC  proteins may 
influence NK cytotoxicity in a tissue specific fashion. Tram- 
fection of the same class I allele in several NK susceptible 
cell lines of different lineages has been shown to induce resis- 
tance only in some (11). 
By far  the most interesting hypothesis is that multiple 
receptors with distinct MHC specifidties may be displayed 
1240  NK3-specific  Natural Killer Cells by NK cells. The NKI-, NK2-, and NK3-specific cell clones 
may preferentially express only one receptor that  has high 
affinity for specific class I HLA epitopes. Thus, these clones 
display a cytotoxic pattern on PHA blasts which appears to 
be regulated by only one HLA molecule or epitope indepen- 
dently of other class I alleles or epitopes on the cell target. 
However, other NK ceils, perhaps the majority, may express 
several receptors for MHC specificities.  Thus, these cells are 
more likely to kill transfectants  expressing only one allele, 
than PHA blasts, which may express up to six different HLA 
alleles. Recently, a multigene family has been described, which 
is primarily expressed in human NK ceils and encodes several 
type II integral membrane proteins with an extracellular  lectin 
domain (26). These proteins are distantly related to the rat 
NKR-Pl molecule (27) and to the Ly-49 protein, which func- 
tions as receptor for class  I molecules on murine NK cells 
(28). Thus, these or related molecules (29) may be candidates 
for the putative multiple inhibitory receptors for class I mol- 
ecules on human  NK cells. 
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